Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

FTSE 100 stocks for 2021! 3 UK shares I’d buy for a tough economic recovery

Want to invest in UK shares but are worried about the economic outlook for 2021? Here are three rock-solid stocks I’d buy for these uncertain times.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Rising Covid-19 infection rates, uncertainty over coronavirus vaccine effectiveness, and the threat of a no-deal Brexit. These are all issues UK share buyers need to seriously consider when investing for 2021.

But these problems are no reason why share investors should stop buying equities altogether. Here are three FTSE 100 stocks I think should thrive next year, regardless of the broader economic landscape.

#1: Safe as houses

An uncertain economic outlook makes Reckitt Benckiser Group (LSE: RB) an ideal pick for UK share investors. It can expect demand for its goods to pick up should shopper spending power bounce back. However, sales here should remain robust irrespective of any recovery. Products such as Dettol disinfectant, Harpic bleach and Vanish stain-removers are must-haves, irrespective of whatever social, economic or political chaos is raging outside our windows.

In fact, companies with popular brands like Reckitt Benckiser stand to gain in a post-Covid-19 landscape. Studies have shown customers have flocked to familiar and trusted labels in 2020 as the world’s been turned upside down. A rising awareness of personal hygiene has also turbocharged demand for the FTSE 100 firm’s germ-killing and laundry-cleaning goods during this calendar year. These changing consumer habits are here to stay too.

#2: A FTSE 100 medical marvel

Healthcare stocks are, of course, reliable investments for uncertain times like these. We don’t stop buying drugs en masse when economic conditions become tough, right? This is why I’d buy GlaxoSmithKline (LSE: GSK) for my Stocks and Shares ISA today.

Business development to success and FTSE 100 250 350 growth concept.

There are many UK pharmaceutical shares for investors to choose from today. But I rate this one for a variety of reasons. I like its terrific geographic exposure, a quality that should underpin strong profits growth in the 2020s as healthcare investment in emerging markets soar. Glaxo’s market-leading products in a variety of therapy areas is also quite appealing.

Finally, I think Glaxo shares look pretty undervalued today. The FTSE 100 giant trades on a price-to-earnings (P/E) ratio of 12 times for 2021. It carries a 5.7% dividend yield too. These figures make the drugs manufacturer one of the best-valued stock on the Footsie.

#3: Another reassuring UK share

Power operator National Grid (LSE: NG) is also one of the safest UK shares for a tough economic climate. Okay, the business isn’t totally immune to downturns as bad debts can rise. But, largely speaking, the essential nature of its operations means it remains a reliable profits generator. This is what makes the business such a great pick for dividend investors.

As the experts at Hargreaves Lansdown comment: “Heavily regulated monopolies have tended to be relatively predictable, and this means they should be able to afford to pay reasonable dividends.”

And the broker reckons National Grid’s dividend should be “sustainable”, despite the obvious regulatory uncertainty that firms like these face.

At current prices, this FTSE 100 share also sports a gigantic forward dividend yield of 5.7%. This makes it a perfect buy for income investors who’re nervous about a lumpy economic recovery in 2021.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young woman holding up three fingers
Investing Articles

Want to start investing in 2026? 3 things to get ready now!

Before someone is ready to start investing in the stock market, our writer reckons it could well be worth them…

Read more »

Investing Articles

Can the stock market continue its strong performance into 2026?

Will the stock market power ahead next year -- or could its recent strong run come crashing down? Christopher Ruane…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Here’s how someone could invest £20k in an ISA to target a 7% dividend yield in 2026

Is 7% a realistic target dividend yield for a Stocks and Shares ISA? Christopher Ruane reckons that it could be.…

Read more »

A quiet morning and an empty Victoria Street in Edinburgh's historic Old Town.
Investing Articles

How little is £1k invested in Greggs shares in January worth now?

Just how much value have Greggs shares lost this year -- and why has our writer been putting his money…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

This cheap FTSE 100 stock outperformed Barclays, IAG, and Games Workshop shares in 2025 but no one’s talking about it

This FTSE stock has delivered fantastic gains in 2025, outperforming a lot of more popular shares. Yet going into 2026,…

Read more »

Close-up of British bank notes
Investing Articles

100 Lloyds shares cost £55 in January. Here’s what they’re worth now!

How well have Lloyds shares done in 2025? Very well is the answer, as our writer explains. But they still…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

How much do you need in an ISA to target £2,000 a month of passive income

Our writer explores a passive income strategy that involves the most boring FTSE 100 share. But when it comes to…

Read more »

Investing Articles

£5,000 invested in a FTSE 250 index tracker at the start of 2025 is now worth…

Despite underperforming the FTSE 100, the FTSE 250 has been the place to find some of the UK’s top growth…

Read more »